1. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14
- Author
-
Parvin Mohazabnia, Philip B. Antiporta, Katherine Doktor, James Riddell, Michelle A. Barron, Fredy Chaparro-Rojas, David Looney, Sandra Cobb, Natalie S. Marzec, Loreen A. Herwaldt, Moira McNulty, Francesca J. Torriani, Connie J. Park, Jared A. Greenberg, Kunatum Prasidthrathsint, Devin M. Weber, Ivette Murphy-Aguilu, Kevin S. Gregg, Becky A. Smith, Susanne Doblecki-Lewis, Courtney Hebert, Suresh Kachhdiya, Vagish Hemmige, Gail E. Reid, Shira R. Abeles, Vanessa Raabe, Christopher R. Cannavino, Belinda Ostrowsky, Julie E. Mangino, Binh Minh Le, Ursula C. Patel, Andrea Green Hines, Alejandro Restrepo, Jeanmarie Schied, Ari Robicsek, Sophie Toya, Sara H Bares, Anindita Chakrabarti, Nirav S. Shah, Zainab Abbas, Stockton Mayer, Monica K. Sikka, Michael Z. David, Priti Patwari, Micah M. Bhatti, and Tonya Scardina
- Subjects
0301 basic medicine ,Male ,Disease ,MRSA ,medicine.disease_cause ,Logistic regression ,Influenza A (H1N1) pdm09 ,0302 clinical medicine ,2.2 Factors relating to the physical environment ,030212 general & internal medicine ,Leukocytosis ,Aetiology ,Child ,Coinfection ,Incidence (epidemiology) ,Incidence ,Bacterial Infections ,Staphylococcal Infections ,Middle Aged ,Co-infection ,Infectious Diseases ,Staphylococcus aureus ,Virus Diseases ,Medical Microbiology ,Child, Preschool ,Pneumonia & Influenza ,Female ,medicine.symptom ,Infection ,Human ,Adult ,medicine.medical_specialty ,Critical Care ,Adolescent ,030106 microbiology ,Clinical Sciences ,Severe influenza ,Microbiology ,Article ,Vaccine Related ,03 medical and health sciences ,Young Adult ,Intensive care ,Internal medicine ,Biodefense ,Virology ,Influenza, Human ,medicine ,Humans ,Preschool ,Retrospective Studies ,Aged ,business.industry ,Prevention ,Infant, Newborn ,Infant ,Retrospective cohort study ,Newborn ,Survival Analysis ,Influenza ,Emerging Infectious Diseases ,Good Health and Well Being ,Immunology ,ICU ,business - Abstract
Highlights • 22.5% of adult patients with H1N1 developed bacterial co-infection. • Staphylococcus aureus was the most common cause of co-infection. • Bacterial and viral co-infections were associated with death in bivariate. • Patients with a bacterial co-infection had greater use of resources., Background Influenza acts synergistically with bacterial co-pathogens. Few studies have described co-infection in a large cohort with severe influenza infection. Objectives To describe the spectrum and clinical impact of co-infections. Study design Retrospective cohort study of patients with severe influenza infection from September 2013 through April 2014 in intensive care units at 33 U.S. hospitals comparing characteristics of cases with and without co-infection in bivariable and multivariable analysis. Results Of 507 adult and pediatric patients, 114 (22.5%) developed bacterial co-infection and 23 (4.5%) developed viral co-infection. Staphylococcus aureus was the most common cause of co-infection, isolated in 47 (9.3%) patients. Characteristics independently associated with the development of bacterial co-infection of adult patients in a logistic regression model included the absence of cardiovascular disease (OR 0.41 [0.23–0.73], p = 0.003), leukocytosis (>11 K/μl, OR 3.7 [2.2–6.2], p
- Published
- 2016
- Full Text
- View/download PDF